Full Paper
[9] a) S. E. V. Phillips, J. Mol. Biol. 1980, 142, 531–554; b) F. Yang, G. N. Phil-
lips, Jr., J. Mol. Biol. 1996, 256, 762–774; c) S.-Y. Park, T. Yokoyama, N.
Shibayama, Y. Shiro, J. R. H. Tame, J. Mol. Biol. 2006, 360, 690–701.
[10] I. Birukou, R. L. Schweers, J. S. Olson, J. Biol. Chem. 2010, 285, 8840–
8854.
[11] H. Dube, B. Kasumaj, C. Calle, M. Saito, G. Jeschke, F. Diederich, Angew.
Chem. Int. Ed. 2008, 47, 2600–2603; Angew. Chem. 2008, 120, 2638–
2642.
7-Co the secondary oxidation product was observed already in
samples that were not intentionally exposed to air or oxygen at
any time. For 8-Co, we could obtain the 8-Co-O2 complex only by
transferring the material into the EPR tube in the air, as was similar-
ly found in the case of 6-Co-O2. However, the relative content of
the species featuring the strongly coupled proton, as was later re-
vealed by Q-band ENDOR measurements, was extremely low. More
details on the oxygenation of 7-Co and 8-Co are provided in Sec-
tion S5.1 in the Supporting Information.
[12] H. Dube, B. Kasumaj, C. Calle, B. Felber, M. Saito, G. Jeschke, F. Dieder-
ich, Chem. Eur. J. 2009, 15, 125–135.
[13] ACD/Percepta, version 14.0.0, Advanced Chemistry Development, Inc.,
For predicting and tuning the pKa values of basic amine centers, see:
M. Morgenthaler, E. Schweizer, A. Hoffmann-Rçder, F. Benini, R. E.
Martin, G. Jaeschke, B. Wagner, H. Fischer, S. Bendels, D. Zimmerli, J.
Schneider, F. Diederich, M. Kansy, K. Mꢂller, ChemMedChem 2007, 2,
1100–1115.
[14] Due to the instability of 2–8-Zn, their purification proved to be very
challenging. In particular, these porphyrins were purified by FC in the
dark (SiO2; solvent, 1% v/v Et3N) and preparative GPC (Jaigel-2H and
NovoGROM 500 or Bio-Beads SX-1).
[15] For the formation of scrambled products under Sonogashira and Suzuki
cross-coupling conditions, see: a) R. W. Wagner, Y. Ciringh, C. Clausen,
J. S. Lindsey, Chem. Mater. 1999, 11, 2974–2983; b) M. Kozaki, S. Morita,
S. Suzuki, K. Okada, J. Org. Chem. 2012, 77, 9447–9457; c) M. N. Alberti,
S. Nowakowska, M. D. Tzirakis, J. Nowakowski, P. Fesser, W. B. Schweizer,
A. Shchyrba, C. Thilgen, T. A. Jung, F. Diederich, Eur. J. Org. Chem. 2014,
5705–5719.
Acknowledgements
This work was supported by the Swiss National Science Foun-
dation (SNF; grant number: 200021-140211). The research of
M.N.A. is implemented within the framework of the Action
“Supporting Postdoctoral Researchers” of the Operational Pro-
gram “Education and Lifelong Learning” (Action’s Beneficiary:
General Secretariat for Research and Technology), and is co-fi-
nanced by the European Social Fund (ESF) and the Greek
State. The authors are especially grateful to Prof. Dr. Willem H.
Koppenol and Dr. Reinhard Kissner for fruitful scientific discus-
sions and for generously providing laboratory facilities. Dr.
Henry Dube is gratefully acknowledged for valuable scientific
discussions and suggestions and Dr. Bruno Bernet for help
with the spectral interpretations. The authors also thank the
ETH NMR service for acquiring some of the 1D/2D NMR spec-
tra.
[16] F. E. Goodson, T. I. Wallow, B. M. Novak, J. Am. Chem. Soc. 1997, 119,
12441–12453.
[17] a) C.-z. Li, K. Nishiyama, I. Taniguchi, Electrochim. Acta 2000, 45, 2883–
2888; b) M. C. Marden, L. Kiger, C. Poyart, A. K. Rashid, J. Kister, F. Stetz-
kowski-Marden, G. Caron, M. Haque, L. Moens, FEBS Lett. 2000, 472,
221–224.
[18] a) J. G. Wilson, F. C. Hunt, Aust. J. Chem. 1983, 36, 2317–2325; b) F.
Maya, J. M. Tour, Tetrahedron 2004, 60, 81–92.
[19] For the synthesis of benzimidazoles from o-nitroanilines and aldehydes
in one step by a reductive cyclization, see: D. Yang, D. Fokas, J. Li, L. Yu,
C. M. Baldino, Synthesis 2005, 47–56.
Keywords: dioxygen binding · ENDOR spectroscopy · heme
proteins
·
hydrogen bond
·
model systems
·
NMR
spectroscopy · porphyrins
[20] M. Belema, A. C. Good, J. Goodrich, R. Kakarla, G. Li, O. D. Lopez, V. N.
Nguyen, J. Kapur, Y. Qiu, J. L. Romine, D. R. St. Laurent, M. Serrano-Wu,
L. B. Snyder, F. Yang (Bristol-Myers Squibb Company), PCT. Int. Appl. WO
2010/017401 A1, 2010.
[21] For a general method of the synthesis of 2-(trifluoromethyl)-1H-benzi-
midazoles, see: G. Navarrete-Vꢃzquez, M. M. Rojano-Vilchis, L. Yꢄpez-
Mulia, V. Melꢄndez, L. Gerena, A. Hernꢃndez-Campos, R. Castillo, F.
Hernꢃndez-Luis, Eur. J. Med. Chem. 2006, 41, 135–141.
ˇ
´
[1] a) J. Vojtechovsky, K. Chu, J. Berendzen, R. M. Sweet, I. Schlichting, Bio-
phys. J. 1999, 77, 2153–2174; b) E. L. Raven, A. G. Mauk, Adv. Inorg.
Chem. 2000, 51, 1–50; c) J. R. H. Tame, B. Vallone, Acta Crystallogr. Sect.
D 2000, 56, 805–811.
[2] a) M. D. Maines, Annu. Rev. Pharmacol. Toxicol. 1997, 37, 517–554; b) Y.
Zhao, P. E. Brandish, D. P. Ballou, M. A. Marletta, Proc. Natl. Acad. Sci. USA
1999, 96, 14753–14758; c) K. Shikama, Prog. Biophys. Mol. Biol. 2006,
91, 83–162.
[22] M. J. Wythes, M. J. Palmer, M. I. Kemp, M. C. Mackenny, R. J. Maguire,
J. F. Blake, Jr., PCT Int. Appl. WO 2000/05231A1, 2000.
[23] P. K. Dubey, A. Naidu, V. Anandam, G. Hemasunder, Indian J. Chem. Sect.
B 2005, 44, 1239–1242.
[24] M. Andrzejewska, M. A. Pagano, F. Meggio, A. M. Brunati, Z. Kazimierc-
zuk, Bioorg. Med. Chem. 2003, 11, 3997–4002.
[25] E. E. Simanek, A. Tsoi, C. C. C. Wang, G. M. Whitesides, M. T. McBride,
G. T. R. Palmore, Chem. Mater. 1997, 9, 1954–1961.
[26] C. J. Diaz, C. D. Haffner, J. D. Speake, C. Zhang, W. Y. Mills, P. K. Spearing,
D. J. Cowan, G. M. Green PCT Int. Appl. WO 2008/021851A2, 2008.
[27] a) D. A. Nugiel, K. Jacobs, L. Cornelius, C.-H. Chang, P. K. Jadhav, E. R.
Holler, R. M. Klabe, L. T. Bacheler, B. Cordova, S. Garber, C. Reid, K. A.
Logue, L. J. Gorey-Feret, G. N. Lam, S. Erickson-Viitanen, S. P. Seitz, J.
Med. Chem. 1997, 40, 1465–1474; b) M. von Wantoch Rekowski, A. Pyr-
iochou, N. Papapetropoulos, A. Stçßel, A. Papapetropoulos, A. Giannis,
Bioorg. Med. Chem. 2010, 18, 1288–1296.
[3] a) J. S. Olson, R. E. McKinnie, M. P. Mims, D. K. White, J. Am. Chem. Soc.
1983, 105, 1522–1527; b) B. A. Springer, S. G. Sligar, J. S. Olson, G. N.
Phillips, Jr., Chem. Rev. 1994, 94, 699–714; c) J. S. Olson, G. N. Phil-
lips, Jr., Biol. Inorg. Chem. 1997, 2, 544–552; d) T. G. Spiro, P. M. Kozlow-
ski, Acc. Chem. Res. 2001, 34, 137–144; e) G. S. Kachalova, A. N. Popov,
H. D. Bartunik, Science 1999, 284, 473–476; f) J. P. Collman, R. Boulatov,
C. J. Sunderland, L. Fu, Chem. Rev. 2004, 104, 561–588; g) J. S. Olson, A.
Ghosh, in The Smallest Biomolecules: Diatomics and their Interactions
with Heme Proteins (Ed.: A. Ghosh), Elsevier, London, 2008, pp. 3–17.
[4] L. Pauling, Nature 1964, 203, 182–183.
[5] a) T. Yonetani, H. Yamamoto, T. Iizuka, J. Biol. Chem. 1974, 249, 2168–
2174; b) M. Ikeda-Saito, T. Iizuka, H. Yamamoto, F. J. Kayne, T. Yonetani,
J. Biol. Chem. 1977, 252, 4882–4887; c) M. Ikeda-Saito, H. Hori, T. Inu-
bushi, T. Yonetani, J. Biol. Chem. 1981, 256, 10267–10271.
[6] a) T. Kitagawa, M. R. Ondrias, D. L. Rousseau, M. Ikeda-Saito, T. Yonetani,
Nature 1982, 298, 869–871; b) K. Nagai, B. Luisi, D. Shih, G. Miyazaki, K.
Imai, C. Poyart, A. De Young, L. Kwiatkowsky, R. W. Noble, S.-H. Lin, N.-T.
Yu, Nature 1987, 329, 858–860.
[28] K. F. Ansari, C. Lal, Eur. J. Med. Chem. 2009, 44, 4028–4033.
[29] B. C. Askew, M. J. Breslin, M. E. Duggan, J. H. Hutchinson, R. S. Meissner,
J. J. Perkins, T. G. Steele, M. A. Patane, PCT Int. Appl. WO 2001/53262A1,
2001.
[7] a) J. Mispelter, M. Momenteau, D. Lavalette, J.-M. Lhoste, J. Am. Chem.
Soc. 1983, 105, 5165–5166; b) J. A. Lukin, V. Simplaceanu, M. Zou, N. T.
Ho, C. Ho, Proc. Natl. Acad. Sci. USA 2000, 97, 10354–10358.
[8] S. E. V. Phillips, B. P. Schoenborn, Nature 1981, 292, 81–82.
[30] P. Weyermann, F. Diederich, Helv. Chim. Acta 2002, 85, 599–617.
[31] a) H. Adams, K. D. M. Harris, G. A. Hembury, C. A. Hunter, D. Livingstone,
J. F. McCabe, Chem. Commun. 1996, 2531–2532; b) C. Allott, H. Adams,
P. L. Bernad, Jr., C. A. Hunter, C. Rotger, J. A. Thomas, Chem. Commun.
&
&
Chem. Eur. J. 2016, 22, 1 – 10
8
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!